- Home
- NFBK vs LAB Comparison
NFBK vs LAB Comparison
Compare NFBK & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NFBK | LAB |
|---|---|---|
| Founded | 1887 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 468.2M | 449.9M |
| IPO Year | 2007 | 2011 |
Fundamental Metrics
Financial Performance| Metric | NFBK | LAB |
|---|---|---|
| Price | $11.61 | $1.29 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $12.67 | $1.35 |
| AVG Volume (30 Days) | 176.8K | ★ 1.5M |
| Earning Date | 01-21-2026 | 11-04-2025 |
| Dividend Yield | ★ 4.43% | N/A |
| EPS Growth | ★ 51.92 | N/A |
| EPS | ★ 0.97 | N/A |
| Revenue | $141,983,000.00 | ★ $169,737,000.00 |
| Revenue This Year | $9.42 | N/A |
| Revenue Next Year | $7.14 | N/A |
| P/E Ratio | $12.06 | ★ N/A |
| Revenue Growth | 13.99 | ★ 79.77 |
| 52 Week Low | $9.40 | $0.92 |
| 52 Week High | $12.50 | $2.14 |
Technical Indicators
Market Signals| Indicator | NFBK | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 51.40 | 38.47 |
| Support Level | $12.09 | $1.46 |
| Resistance Level | $11.94 | $1.72 |
| Average True Range (ATR) | 0.28 | 0.09 |
| MACD | -0.07 | -0.03 |
| Stochastic Oscillator | 29.74 | 2.25 |
Price Performance
Historical ComparisonAbout NFBK Northfield Bancorp Inc. (Delaware)
Northfield Bancorp Inc is the holding company for Northfield Bank. Its subsidiary provides banking services to individuals and corporate customers in Richmond and Kings Counties in New York, and Hunterdon, Mercer, Union and Middlesex counties in New Jersey. The bank attracts deposits and offers credit and other banking services.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.